Paúl E. Clavijo

2.2k total citations
33 papers, 1.6k citations indexed

About

Paúl E. Clavijo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Paúl E. Clavijo has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 19 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Paúl E. Clavijo's work include Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (9 papers) and Immune Cell Function and Interaction (7 papers). Paúl E. Clavijo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (14 papers), Immune cells in cancer (9 papers) and Immune Cell Function and Interaction (7 papers). Paúl E. Clavijo collaborates with scholars based in United States, Spain and China. Paúl E. Clavijo's co-authors include Clint Allen, Carter Van Waes, Jay Friedman, Ellen Moore, Yvette Robbins, Ruth J. Davis, Jeffrey Schlom, Lillian Sun, Harrison Cash and Sarah Greene and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Paúl E. Clavijo

32 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paúl E. Clavijo United States 20 1.0k 1.0k 390 245 165 33 1.6k
Hampartsoum B. Barsoumian United States 25 709 0.7× 937 0.9× 426 1.1× 425 1.7× 258 1.6× 57 1.6k
Sylvia M. Lee United States 13 733 0.7× 986 1.0× 328 0.8× 149 0.6× 90 0.5× 19 1.3k
Anne M. van der Leun Netherlands 8 1000 1.0× 1.0k 1.0× 567 1.5× 240 1.0× 228 1.4× 9 1.6k
Claire Lhuillier United States 12 927 0.9× 1.2k 1.2× 263 0.7× 370 1.5× 147 0.9× 15 1.7k
Shuji Kitahara Japan 14 472 0.5× 707 0.7× 425 1.1× 229 0.9× 284 1.7× 32 1.4k
Shuhua Wei China 12 559 0.5× 443 0.4× 347 0.9× 195 0.8× 157 1.0× 21 1.1k
Amandine Alard United States 10 724 0.7× 851 0.8× 576 1.5× 315 1.3× 169 1.0× 13 1.6k
Ilenia Pellicciotta United States 14 666 0.6× 742 0.7× 313 0.8× 190 0.8× 94 0.6× 24 1.2k
Miren Zuazo Spain 17 760 0.7× 1.0k 1.0× 296 0.8× 195 0.8× 123 0.7× 27 1.4k
Federico Sandoval France 9 594 0.6× 777 0.8× 306 0.8× 179 0.7× 147 0.9× 16 1.1k

Countries citing papers authored by Paúl E. Clavijo

Since Specialization
Citations

This map shows the geographic impact of Paúl E. Clavijo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paúl E. Clavijo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paúl E. Clavijo more than expected).

Fields of papers citing papers by Paúl E. Clavijo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paúl E. Clavijo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paúl E. Clavijo. The network helps show where Paúl E. Clavijo may publish in the future.

Co-authorship network of co-authors of Paúl E. Clavijo

This figure shows the co-authorship network connecting the top 25 collaborators of Paúl E. Clavijo. A scholar is included among the top collaborators of Paúl E. Clavijo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paúl E. Clavijo. Paúl E. Clavijo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clavijo, Paúl E., et al.. (2024). Heterogeneous characterization of neutrophilic cells in head and neck cancers. Head & Neck. 46(10). 2591–2599. 1 indexed citations
2.
Bai, Ke, Paúl E. Clavijo, Yvette Robbins, Scott M. Norberg, & Clint Allen. (2024). Quantification and Functional Studies of Neutrophilic Cells Identifies Distinct Papilloma Phenotypes. The Laryngoscope. 134(7). 3238–3244. 5 indexed citations
3.
Morgan, Ethan L., Anthony D. Saleh, Hui Cheng, et al.. (2024). Functional RNAi Screening Identifies G2/M and Kinetochore Components as Modulators of TNFα/NF-κB Prosurvival Signaling in Head and Neck Squamous Cell Carcinoma. Cancer Research Communications. 4(11). 2903–2918. 2 indexed citations
4.
Clavijo, Paúl E., et al.. (2024). Complete tumor resection reverses neutrophilia-associated suppression of systemic anti-tumor immunity. Oral Oncology. 150. 106705–106705. 4 indexed citations
5.
Sakakibara, Nozomi, Paúl E. Clavijo, Cem Sievers, et al.. (2023). Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. Frontiers in Immunology. 14. 1200970–1200970.
6.
Viswanathan, Ramya, Hui Cheng, Jianghong Chen, et al.. (2022). Inhibiting WEE1 and IKK-RELA crosstalk overcomes TNFa resistance in head and neck cancers. Figshare. 13 indexed citations
7.
Asuzu, David T., Patrick A. Fletcher, Debjani Mandal, et al.. (2022). Pituitary adenomas evade apoptosis via noxa deregulation in Cushing’s disease. Cell Reports. 40(8). 111223–111223. 15 indexed citations
8.
Sievers, Cem, Yvette Robbins, Ke Bai, et al.. (2021). Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. Communications Biology. 4(1). 1416–1416. 17 indexed citations
9.
Robbins, Yvette, Sarah Greene, Jay Friedman, et al.. (2020). Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife. 9. 43 indexed citations
10.
Nagaya, Tadanobu, Jay Friedman, Yasuhiro Maruoka, et al.. (2019). Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Cancer Immunology Research. 7(3). 401–413. 123 indexed citations
11.
Greene, Sarah, Yvette Robbins, Wojciech K. Mydlarz, et al.. (2019). Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical Cancer Research. 26(6). 1420–1431. 217 indexed citations
12.
Friedman, Jay, Ellen Moore, Paul Zolkind, et al.. (2019). Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells. Clinical Cancer Research. 26(3). 679–689. 57 indexed citations
13.
Allen, Clint, Sunmin Lee, Scott M. Norberg, et al.. (2019). Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis. Journal for ImmunoTherapy of Cancer. 7(1). 119–119. 41 indexed citations
14.
Sun, Lillian, Paúl E. Clavijo, Yvette Robbins, et al.. (2019). Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy. JCI Insight. 4(7). 188 indexed citations
15.
Zhang, Jialing, Chien‐Jen Chen, Xinping Yang, et al.. (2018). Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. Cancer Research. 78(16). 4613–4626. 35 indexed citations
16.
Clavijo, Paúl E., Jay Friedman, Yvette Robbins, et al.. (2018). Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function. Cancer Immunology Research. 7(2). 282–291. 40 indexed citations
17.
Clavijo, Paúl E., et al.. (2018). Non-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report. Anales del Sistema Sanitario de Navarra. 41(2). 263–267. 1 indexed citations
18.
Davis, Ruth J., Ellen Moore, Paúl E. Clavijo, et al.. (2017). Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. Cancer Research. 77(10). 2607–2619. 178 indexed citations
19.
Clavijo, Paúl E., et al.. (2016). Endoscopic treatment in an elderly patient with Bouveret syndrome. Anales del Sistema Sanitario de Navarra. 39(3). 429–432. 1 indexed citations
20.
Moore, Ellen, Paúl E. Clavijo, Ruth J. Davis, et al.. (2016). Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade. Cancer Immunology Research. 4(12). 1061–1071. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hampartsoum B. Barsoumian Breakdown of academic impact, for papers by Sylvia M. Lee Breakdown of academic impact, for papers by Anne M. van der Leun Breakdown of academic impact, for papers by Claire Lhuillier Breakdown of academic impact, for papers by Shuji Kitahara Breakdown of academic impact, for papers by Shuhua Wei Breakdown of academic impact, for papers by Amandine Alard Breakdown of academic impact, for papers by Ilenia Pellicciotta Breakdown of academic impact, for papers by Miren Zuazo Breakdown of academic impact, for papers by Federico Sandoval
Rankless by CCL
2026